Salivadirect Inc
- Assets
- $1.2m
- Revenue
- $1.6m
- Investments
- $0.0
- Employees
- 9
- Location
- New Haven, CT
- Founding
- Data as of
- 12/2023
- EIN
- 92-1054959
Organization Overview
Salivadirect Inc is located in New Haven, CT. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. As of 12/2023, Salivadirect Inc employed 9 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Salivadirect Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO ESTABLISH, OPERATE OR MAINTAIN LABORATORIES ENGAGED IN BIOSCIENTIFIC RESEARCH AND OTHER ACTIVITIES TO SUPPORT SURVEILLANCE TESTING THROUGH THE PERFORMANCE OF SALIVA BASED TESTING.
Describe the Organization's Program Activity:
Part 3 - Line 4a
A KEY ACCOMPLISHMENT HAS BEEN THE SUCCESSFUL IMPLEMENTATION OF SALIVADIRECT TESTING IN MALAWI. THE TEAM CONDUCTED COMPREHENSIVE TRAINING FOR LOCAL LABORATORY SCIENTISTS, TRANSFERRING KNOWLEDGE AND SKILLS TO BUILD LOCAL CAPACITY. THEY HAVE MADE SUBSTANTIAL PROGRESS IN COMPARING THE PERFORMANCE OF SALIVA SAMPLES TO PAIRED NASOPHARYNGEAL SWABS FOR DETECTING RESPIRATORY VIRUSES. PRELIMINARY RESULTS SHOW SUBSTANTIAL AGREEMENT FOR SARS-COV-2, RSV, AND INFLUENZA B DETECTION BETWEEN THE TWO SAMPLE TYPES, WITH SALIVA DETECTING SIGNIFICANTLY MORE INFLUENZA A CASES.
INITIATION OF SALIVA DIRECT INC LAB NETWORK SUSTAINABILITY PLAN THROUGH FEDERAL DRUG ADMINISTRATION FDA ENGAGEMENT IN PREPARING THE DE NOVO AUTHORIZATION OF THE SARS-COV-2 ASSAY, EXPANDING ASSAY DEVELOPMENT TO INCLUDE SARS-COV-2, INFLUENZA A/B AND RSV IN A MULTIPLEX PCR ASSAY, AND LAUNCHING MOBILE TESTING ACCROSS NEW HAVEN BY PARTNERING WITH 22 COMMUNITY ORGANIZATIONS. THE MOBILE TESTING WAS DEPLOYED TO 123 EVENTS ACROSS CONNECTICUT, PROVIDING 1,428 FREE SARS-COV-2 TESTS EXCEDDING THE GOAL OF 400 TESTS WITH HIGH ENGAGEMENT FROM UNINSURED AND UNDERSERVED COMMUNITIES. THE KEY FINDINGS INDICATED THAT 74 OF PARTICIPANTS FOUND IT EASY TO ACCESS THE VAN AND 75 WERE COMFORTABLE WITH USING THE SERVICES DEMONSTRATING THE EFFECTIVENESS OF MOBILE TESTING IN OVERCOMING BARRIERS SUCH AS TRANSPORTATION, ACCESS TO HEALTHCARE AND SHOWING OF STRONG INTEREST IN EXPANDING MOBILE HEALTH SERVICES TO INCLUDE HEALTH SCREENINGS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Yasmine Ali Executive Director | Officer | 35 | $68,247 |
Brittany Choate Program Manager | Officer | 35 | $43,863 |
Russell Thomas Senior Business Associate | Officer | 35 | $40,460 |
Laura Burke Regulatory And Compliance Manager | Officer | 35 | $37,898 |
Robby Sikka Chairman Of The Board | OfficerTrustee | 2 | $0 |
Anne Wylie Director | Trustee | 2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $305,616 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $305,616 |
| Total Program Service Revenue | $1,284,113 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,589,729 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $190,882 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $333,922 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $13,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $27,255 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $142,449 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,102 |
| Insurance | $2,639 |
| All other expenses | $0 |
| Total functional expenses | $799,983 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $169,749 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $1,064,386 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $4,404 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,238,539 |
| Accounts payable and accrued expenses | $13,000 |
| Grants payable | $0 |
| Deferred revenue | $435,793 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $448,793 |
| Net assets without donor restrictions | $789,746 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,238,539 |